{"pmid":32454394,"title":"Arterial thrombosis and coronavirus disease 2019 in a patient with cancer.","text":["Arterial thrombosis and coronavirus disease 2019 in a patient with cancer.","Eur J Cancer","Nassabein, Rami","Routy, Bertrand","Blais, Normand","Ayoub, Jean-Pierre","Tehfe, Mustapha","32454394"],"journal":"Eur J Cancer","authors":["Nassabein, Rami","Routy, Bertrand","Blais, Normand","Ayoub, Jean-Pierre","Tehfe, Mustapha"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454394","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.ejca.2020.05.002","topics":["Case Report"],"weight":1,"_version_":1667881798483312640,"score":9.490897,"similar":[{"pmid":32503080,"title":"Concomitant brain arterial and venous thrombosis in a COVID-19 patient.","text":["Concomitant brain arterial and venous thrombosis in a COVID-19 patient.","COVID-19 infection can cause a severe pneumonia which, in some cases, can lead to admission in intensive care unit for respiratory support.(1) In severe cases, systemic thrombotic complication has been described, including cerebrovascular disease (5.7-23% of cases).(2,3).","Eur J Neurol","Malentacchi, Maria","Gned, Dario","Angelino, Valeria","Demichelis, Sara","Perboni, Alberto","Veltri, Andrea","Bertolotto, Antonio","Capobianco, Marco","32503080"],"abstract":["COVID-19 infection can cause a severe pneumonia which, in some cases, can lead to admission in intensive care unit for respiratory support.(1) In severe cases, systemic thrombotic complication has been described, including cerebrovascular disease (5.7-23% of cases).(2,3)."],"journal":"Eur J Neurol","authors":["Malentacchi, Maria","Gned, Dario","Angelino, Valeria","Demichelis, Sara","Perboni, Alberto","Veltri, Andrea","Bertolotto, Antonio","Capobianco, Marco"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32503080","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/ene.14380","topics":["Case Report"],"weight":1,"_version_":1668890966372646914,"score":49.084576},{"pmid":32425264,"pmcid":"PMC7229939","title":"Severe arterial thrombosis associated with Covid-19 infection.","text":["Severe arterial thrombosis associated with Covid-19 infection.","*Increased incidence of venous thrombosis has been demonstrated in SARS-CoV2 infected patients but no data are available for arterial thrombosis.*We observed very severe arterial thrombotic complications in COVID-19 patients with cardiovascular history despite the use of antiplatelet or anticoagulant therapy, including five irreversible lower limb ischemia and two thoracic aortic free floating thrombi.*Three patients were in intensive care unit (ICU) and two of them also presented VTE, one deep vein thrombosis and one segmental PE.*Further studies are needed to evaluate the necessity of therapeutic anticoagulation in COVID-19 patients with peripheral arterial occlusive disease or thrombophilia.","Thromb Res","Kashi, Mahine","Jacquin, Aurelien","Dakhil, Bassel","Zaimi, Rym","Mahe, Emmanuel","Tella, Emilie","Bagan, Patrick","32425264"],"abstract":["*Increased incidence of venous thrombosis has been demonstrated in SARS-CoV2 infected patients but no data are available for arterial thrombosis.*We observed very severe arterial thrombotic complications in COVID-19 patients with cardiovascular history despite the use of antiplatelet or anticoagulant therapy, including five irreversible lower limb ischemia and two thoracic aortic free floating thrombi.*Three patients were in intensive care unit (ICU) and two of them also presented VTE, one deep vein thrombosis and one segmental PE.*Further studies are needed to evaluate the necessity of therapeutic anticoagulation in COVID-19 patients with peripheral arterial occlusive disease or thrombophilia."],"journal":"Thromb Res","authors":["Kashi, Mahine","Jacquin, Aurelien","Dakhil, Bassel","Zaimi, Rym","Mahe, Emmanuel","Tella, Emilie","Bagan, Patrick"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425264","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.thromres.2020.05.025","keywords":["arterial thrombosis","covid-19","floating aortic thrombus","lower limb ischemia","sars-cov2 infection"],"locations":["thoracic"],"topics":["Case Report"],"weight":1,"_version_":1667252837779767296,"score":48.732426},{"pmid":32424482,"title":"Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19.","text":["Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19.","Intensive Care Med","Azouz, Eya","Yang, Sisi","Monnier-Cholley, Laurence","Arrive, Lionel","32424482"],"journal":"Intensive Care Med","authors":["Azouz, Eya","Yang, Sisi","Monnier-Cholley, Laurence","Arrive, Lionel"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32424482","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s00134-020-06079-2","topics":["Case Report"],"weight":1,"_version_":1667252837830098945,"score":47.372635},{"pmid":32399456,"pmcid":"PMC7213834","title":"Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection.","text":["Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection.","A 52-year-old patient with SARS-CoV-2 was diagnosed with interstitial pneumonia and treated with darunavir/ritonavir, hydroxychloroquine, azithromycin and low molecular weight heparin (LMWH). After LMWH cessation, he developed superior mesenteric arterial thrombosis. An abdominal CT scan showed arterial thrombosis of vessels efferent of the superior mesenteric artery with bowel distension. COVID-19 may predispose to venous and arterial thromboembolism. Anticoagulation prophylaxis should be considered in hospitalized patients with COVID-19, and potential thromboembolism investigated in each symptomatic patient affected by SARS-CoV-2. LEARNING POINTS: Potential thromboembolism must be investigated in each symptomatic patient with SARS-CoV-2 infection.The preventive and therapeutic use of antithrombotic agents should be strongly considered in order to mitigate thrombotic and haemorrhagic events in patients with SARS-CoV-2 infection.","Eur J Case Rep Intern Med","A Beccara, Lia","Pacioni, Carlotta","Ponton, Sara","Francavilla, Simone","Cuzzoli, Antonio","32399456"],"abstract":["A 52-year-old patient with SARS-CoV-2 was diagnosed with interstitial pneumonia and treated with darunavir/ritonavir, hydroxychloroquine, azithromycin and low molecular weight heparin (LMWH). After LMWH cessation, he developed superior mesenteric arterial thrombosis. An abdominal CT scan showed arterial thrombosis of vessels efferent of the superior mesenteric artery with bowel distension. COVID-19 may predispose to venous and arterial thromboembolism. Anticoagulation prophylaxis should be considered in hospitalized patients with COVID-19, and potential thromboembolism investigated in each symptomatic patient affected by SARS-CoV-2. LEARNING POINTS: Potential thromboembolism must be investigated in each symptomatic patient with SARS-CoV-2 infection.The preventive and therapeutic use of antithrombotic agents should be strongly considered in order to mitigate thrombotic and haemorrhagic events in patients with SARS-CoV-2 infection."],"journal":"Eur J Case Rep Intern Med","authors":["A Beccara, Lia","Pacioni, Carlotta","Ponton, Sara","Francavilla, Simone","Cuzzoli, Antonio"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399456","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.12890/2020_001690","keywords":["covid-19","mesenteric thrombosis","abdominal pain"],"e_drugs":["Hydroxychloroquine","Azithromycin","Heparin, Low-Molecular-Weight"],"topics":["Case Report"],"weight":1,"_version_":1666714494757240833,"score":46.950447},{"pmid":32353183,"title":"Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19.","text":["Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19.","SARS-CoV-2 infection has been reported to induce a hypercoagulable state(1) which is associated with disease severity and poor outcomes.(2,3) Rates of thromboembolic events and use of augmented thromboprophylaxis in patients with COVID-19 are therefore the subject of significant interest. However, the clinical manifestations of this procoagulant tendency are poorly defined. In this report we describe two cases of major occlusive arterial events in previously asymptomatic individuals with confirmed COVID-19.","Br J Haematol","Vulliamy, Paul","Jacob, Sabu","Davenport, Ross A","32353183"],"abstract":["SARS-CoV-2 infection has been reported to induce a hypercoagulable state(1) which is associated with disease severity and poor outcomes.(2,3) Rates of thromboembolic events and use of augmented thromboprophylaxis in patients with COVID-19 are therefore the subject of significant interest. However, the clinical manifestations of this procoagulant tendency are poorly defined. In this report we describe two cases of major occlusive arterial events in previously asymptomatic individuals with confirmed COVID-19."],"journal":"Br J Haematol","authors":["Vulliamy, Paul","Jacob, Sabu","Davenport, Ross A"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353183","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/bjh.16760","topics":["Case Report"],"weight":1,"_version_":1666138495602655232,"score":43.885754}]}